4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0000950170-25-081637
Principal Accounting Officer sold 2,062 shares at $4.45 ($9,174)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dunn Edmund Principal Accounting Officer | 2025-06-03 | Sale | −2,062 | $4.45 | $9,174 | 23,732 | D |
| Open-market sales · 2,062 sh · avg $4.45 · $9,174 | |||||||
Loading xslF345X05/ownership.xml…